Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with P

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
6279 Q3 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 4.30 mg Correction
6279 Q4 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 2.50 mg Correction
6559 Q3 2021 POLYVINYL ACETATE ORAL TABLET 19.24 mg Correction
6559 Q4 2021 POLYVINYL ACETATE ORAL TABLET 7.00 mg Correction
6847 Q3 2021 PPG-11 STEARYL ETHER TOPICAL AEROSOL, FOAM 5.00 %w/w Correction
6847 Q4 2021 POLYPROPYLENE GLYCOL 11 STEARYL ETHER TOPICAL AEROSOL, FOAM 5.00 %w/w Correction
6848 Q3 2021 PPG-11 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6848 Q4 2021 POLYPROPYLENE GLYCOL 11 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6851 Q3 2021 PPG-15 STEARYL ETHER TOPICAL GEL 2.00 %w/w Correction
6851 Q4 2021 POLYPROPYLENE GLYCOL 15 STEARYL ETHER TOPICAL GEL 2.00 %w/w Correction
6852 Q3 2021 PPG-15 STEARYL ETHER TOPICAL OINTMENT 15.00 %w/w Correction
6852 Q4 2021 POLYPROPYLENE GLYCOL 15 STEARYL ETHER TOPICAL OINTMENT 15.00 %w/w Correction
6853 Q3 2021 PPG-15 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6853 Q4 2021 POLYPROPYLENE GLYCOL 15 STEARYL ETHER TOPICAL SUSPENSION 16.00 %w/w Correction
6873 Q3 2021 POVIDONE K15 TOPICAL SYSTEM 280.00 mg Correction
6873 Q4 2021 POVIDONE K90 TOPICAL SYSTEM 280 mg Correction
6874 Q3 2021 POVIDONE K27 ORAL TABLET, EXTENDED RELEASE 10.00 mg Correction
6874 Q4 2021 POVIDONE K27 ORAL TABLET, EXTENDED RELEASE 10.00 mg Correction
6938 Q3 2021 PROPYLENE GLYCOL TOPICAL CLOTH 15.00 mg Correction
6938 Q4 2021 PROPYLENE GLYCOL TOPICAL CLOTH 0.02 mg/mg Correction
5860 Q3 2021 PEPPERMINT OIL BUCCAL FILM, SOLUBLE 0.85 mg MDE Replacement
5860 Q4 2021 PEPPERMINT OIL BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
5875 Q3 2021 PEPPERMINT OIL SUBLINGUAL POWDER 0.40 mg MDE Replacement
5875 Q4 2021 PEPPERMINT OIL SUBLINGUAL POWDER 1.2 mg MDE Replacement
5928 Q3 2021 PHENOXYETHANOL TOPICAL CREAM 1.00 %w/w MDE Replacement
5928 Q4 2021 PHENOXYETHANOL TOPICAL CREAM 57 mg MDE Replacement
5938 Q3 2021 PHENYLETHYL ALCOHOL NASAL SPRAY, METERED 2.50 mg MDE Replacement
5938 Q4 2021 PHENYLETHYL ALCOHOL NASAL SPRAY, METERED 10 mg MDE Replacement
5995 Q3 2021 PLASACRYL T20 ORAL CAPSULE, EXTENDED RELEASE 3.98 mg MDE Replacement
5995 Q4 2021 PLASACRYL T20 ORAL CAPSULE, EXTENDED RELEASE 3.98 mg MDE Replacement
6001 Q3 2021 POLACRILIN POTASSIUM ORAL CAPSULE 45.28 mg MDE Replacement
6001 Q4 2021 POLACRILIN POTASSIUM ORAL CAPSULE 54.95 mg MDE Replacement
6003 Q3 2021 POLACRILIN POTASSIUM ORAL SUSPENSION 20.00 mg/ 5.00 ml MDE Replacement
6003 Q4 2021 POLACRILIN POTASSIUM ORAL SUSPENSION 120 mg MDE Replacement
6046 Q3 2021 POLOXAMER 407 ORAL CAPSULE, DELAYED RELEASE 5.00 mg MDE Replacement
6046 Q4 2021 POLOXAMER 407 ORAL CAPSULE, DELAYED RELEASE 5 mg MDE Replacement
6064 Q3 2021 POLYCARBOPHIL BUCCAL FILM, SOLUBLE 1.37 mg MDE Replacement
6064 Q4 2021 POLYCARBOPHIL BUCCAL FILM, SOLUBLE 5.48 mg MDE Replacement
6173 Q3 2021 POLYETHYLENE GLYCOL 400 INTRAVENOUS INJECTION 7470.00 mg MDE Replacement
6173 Q4 2021 POLYETHYLENE GLYCOL 400 INTRAVENOUS INJECTION 25013.3 mg MDE Replacement
6224 Q3 2021 POLYETHYLENE GLYCOL 4000 ORAL TABLET, FILM COATED 4.20 mg MDE Replacement
6224 Q4 2021 POLYETHYLENE GLYCOL 4000 ORAL TABLET, FILM COATED 4.5 mg MDE Replacement
6274 Q3 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, EXTENDED RELEASE 144.60 mg MDE Replacement
6274 Q4 2021 POLYETHYLENE GLYCOL 8000 ORAL TABLET, EXTENDED RELEASE 242 mg MDE Replacement
6294 Q3 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET 173.99 mg MDE Replacement
6294 Q4 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET 347.98 mg MDE Replacement
6295 Q3 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET, EXTENDED RELEASE 345.00 mg MDE Replacement
6295 Q4 2021 POLYETHYLENE OXIDE 200000 ORAL TABLET, EXTENDED RELEASE 460 mg MDE Replacement
6298 Q3 2021 POLYETHYLENE OXIDE 4000000 ORAL TABLET, EXTENDED RELEASE 188.10 mg MDE Replacement
6298 Q4 2021 POLYETHYLENE OXIDE 4000000 ORAL TABLET, EXTENDED RELEASE 250.8 mg MDE Replacement
6300 Q3 2021 POLYETHYLENE OXIDE 7000000 ORAL TABLET 132.66 mg MDE Replacement
6300 Q4 2021 POLYETHYLENE OXIDE 7000000 ORAL TABLET 265.32 mg MDE Replacement
6324 Q3 2021 POLYISOBUTYLENE (1100000 MW) TOPICAL SYSTEM 66.78 mg MDE Replacement
6324 Q4 2021 POLYISOBUTYLENE (1100000 MW) TOPICAL SYSTEM 66.78 mg MDE Replacement
6517 Q3 2021 POLYSORBATE 80 ORAL GRANULE, FOR SUSPENSION 15.00 mg MDE Replacement
6517 Q4 2021 POLYSORBATE 80 ORAL GRANULE, FOR SUSPENSION 125 mg MDE Replacement
6561 Q3 2021 POLYVINYL ACETATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 25.82 mg MDE Replacement
6561 Q4 2021 POLYVINYL ACETATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 38.74 mg MDE Replacement
6653 Q3 2021 POTASSIUM CHLORIDE ORAL TABLET, EXTENDED RELEASE 9.90 mg MDE Replacement
6653 Q4 2021 POTASSIUM CHLORIDE ORAL TABLET, EXTENDED RELEASE 13.2 mg MDE Replacement
6656 Q3 2021 POTASSIUM CITRATE ORAL POWDER, FOR SOLUTION 175.00 mg MDE Replacement
6656 Q4 2021 POTASSIUM CITRATE ORAL POWDER, FOR SOLUTION 490 mg MDE Replacement
6788 Q3 2021 POVIDONE K30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 8.18 mg MDE Replacement
6788 Q4 2021 POVIDONE K30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 12.28 mg MDE Replacement
6818 Q3 2021 POVIDONE K90 ORAL TABLET 78.00 mg MDE Replacement
6818 Q4 2021 POVIDONE K90 ORAL TABLET 525 mg MDE Replacement
6838 Q3 2021 POWDERED CELLULOSE ORAL TABLET 560.00 mg MDE Replacement
6838 Q4 2021 POWDERED CELLULOSE ORAL TABLET 1582.4 mg MDE Replacement
6843 Q3 2021 POWDERED CELLULOSE ORAL TABLET, FILM COATED 391.70 mg MDE Replacement
6843 Q4 2021 POWDERED CELLULOSE ORAL TABLET, FILM COATED 391.7 mg MDE Replacement
6867 Q3 2021 PROPYL GALLATE ORAL CAPSULE 2.00 mg MDE Replacement
6867 Q4 2021 PROPYL GALLATE ORAL CAPSULE 4 mg MDE Replacement
Q3 2021 PROPYLENE GLYCOL BUCCAL FILM, SOLUBLE 1.02 mg MDE Replacement
Q4 2021 PROPYLENE GLYCOL BUCCAL FILM, SOLUBLE 4 mg MDE Replacement
6887 Q3 2021 PROPYLENE GLYCOL INTRAMUSCULAR INJECTION, SOLUTION 41.60 %w/v MDE Replacement
6887 Q4 2021 PROPYLENE GLYCOL INTRAMUSCULAR INJECTION, SOLUTION 4000 mg MDE Replacement
6902 Q3 2021 PROPYLENE GLYCOL ORAL CAPSULE 148.31 mg MDE Replacement
6902 Q4 2021 PROPYLENE GLYCOL ORAL CAPSULE 700 mg MDE Replacement
6924 Q3 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED 14.62 mg MDE Replacement
6924 Q4 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED 154 mg MDE Replacement
6925 Q3 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED, EXTENDED RELEASE 12.80 mg MDE Replacement
6925 Q4 2021 PROPYLENE GLYCOL ORAL TABLET, FILM COATED, EXTENDED RELEASE 19.2 mg MDE Replacement
6935 Q3 2021 PROPYLENE GLYCOL SUBLINGUAL SPRAY 4.50 mg/ 1.00 ml MDE Replacement
6935 Q4 2021 PROPYLENE GLYCOL SUBLINGUAL SPRAY 36 mg MDE Replacement
6943 Q3 2021 PROPYLENE GLYCOL TOPICAL GEL, METERED 35.00 %w/w MDE Replacement
6943 Q4 2021 PROPYLENE GLYCOL TOPICAL GEL, METERED 1225 mg MDE Replacement
6959 Q3 2021 PROPYLENE GLYCOL VAGINAL CREAM 20.00 %w/w MDE Replacement
6959 Q4 2021 PROPYLENE GLYCOL VAGINAL CREAM 400 mg MDE Replacement
Q3 2021 PROPYLPARABEN BUCCAL FILM, SOLUBLE 0.18 mg MDE Replacement
Q4 2021 PROPYLPARABEN BUCCAL FILM, SOLUBLE 0.72 mg MDE Replacement
7047 Q3 2021 PROPYLPARABEN TOPICAL GEL 0.05 %w/w MDE Replacement
7047 Q4 2021 PROPYLPARABEN TOPICAL GEL 1 mg MDE Replacement
6263 Q4 2021 POLYETHYLENE GLYCOL 6000 VAGINAL INSERT 0.10 mg Deletion
6359 Q4 2021 POLYOXYL 35 CASTOR OIL ORAL SOLUTION/ DROPS 50.00 mg/ 1.00 ml Deletion
6589 Q4 2021 POLYVINYL ALCOHOL VAGINAL TABLET 20.60 mg Deletion
6760 Q4 2021 POVIDONE K27 ORAL TABLET 26.60 mg Deletion
6762 Q4 2021 POVIDONE K30 BUCCAL TABLET, DELAYED RELEASE 0.50 mg 0.5 mg Deletion

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English